DOW INC. DL-,01/ US2605571031 /
2024-04-18 4:14:26 PM | Chg. -0.050 | Volume | Bid4:33:10 PM | Ask4:33:10 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
53.260EUR | -0.09% | 19 Turnover: 1,011.230 |
53.210Bid Size: 193 | 53.260Ask Size: 193 | 37.33 bill.EUR | - | - |
GlobeNewswire
02-13
Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors
GlobeNewswire
01-22
60 Degrees Pharma Plans Pivotal Babesiosis Study with Tafenoquine Following Jan 17 FDA Meeting
GlobeNewswire
2023-11-16
Dow Jones Appoints Global Agency Partners to Accelerate Marketing Transformation and Subscription Gr...
GlobeNewswire
2023-10-11
Dow Jones Risk & Compliance Completes ISAE 3000 Assurance for Ninth Consecutive Year
GlobeNewswire
2023-09-06
60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conferenc...
GlobeNewswire
2021-11-17
Gildan Included on the 2021 Dow Jones Sustainability Index for the Ninth Consecutive Year